Learn about the latest immunotherapy innovations including novel biomarkers, factors that impact duration of response, bioinformatic approaches to mass cytometry, the use of t-SNE and PCA, and the role of TNF in resistance to immunotherapy and tumor escape in a solid tumor model. Read more about Plenary Session 5.
Patrick Hanley, PhD
Children’s National Medical Center
United States
Session Chair
Cameron Turtle, MBBS, PhD
Fred Hutchinson Cancer Research Center
United States
Speaker
Jane Oliaro, BSc (Hons), PhD
Peter MacCallum Cancer Centre
United States
Speaker
Emily Blyth, B. Med (Hons), PhD
Westmead Hospital
Australia
Speaker
Don’t miss the chance to make new contacts, connect with current clients, develop your cell therapy, regenerative medicine and gene therapy business.
Established in 1992, ISCT is a global society of clinicians, researchers, regulators, technologists and industry partners with a shared vision to translate safe and effective cell & gene therapies to improve patients’ lives worldwide.
Everyone who is not a New Zealand or Norfolk Island resident will need a visa to enter Australia. Please apply for your visa ASAP to ensure it is received in time.
Location
1 Convention Centre Pl
South Wharf VIC 3006 Australia
Learn
Sessions to improve every aspect of cell therapy
